par Ravoet, Christophe;DeGrève, J;Vandewoude, K;Kerger, Joseph 
;Sculier, Jean-Paul ;Lacor, Patrick;Stryckmans, Pierre ;Piccart-Gebhart, Martine
Référence Lancet, 344, 8936, page (1576-1577)
Publication Publié, 1994-12
;Sculier, Jean-Paul ;Lacor, Patrick;Stryckmans, Pierre ;Piccart-Gebhart, Martine Référence Lancet, 344, 8936, page (1576-1577)
Publication Publié, 1994-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Ravoet, Christophe; DeGrève, J; Vandewoude, K; Kerger, Joseph; Sculier, Jean-Paul; Lacor, Patrick; Stryckmans, Pierre; Piccart-Gebhart, Martine |
| Informations sur la publication: | Lancet, 344, 8936, page (1576-1577) |
| Statut de publication: | Publié, 1994-12 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Carcinoma, Renal Cell -- pathology | |
| Carcinoma, Renal Cell -- therapy | |
| Female | |
| Humans | |
| Interleukin-6 -- adverse effects | |
| Kidney Neoplasms -- pathology | |
| Kidney Neoplasms -- therapy | |
| Liver Neoplasms -- secondary | |
| Liver Neoplasms -- therapy | |
| Lung Neoplasms -- secondary | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase I | |
| Letter | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0140-6736 |
| info:pmid/7983975 |
